Telomere profiling: toward glioblastoma personalized medicine. - Wikidata - wikimedia - TriplyDB

Telomere profiling: toward glioblastoma personalized medicine.

Telomere profiling: toward glioblastoma personalized medicine.

http://www.wikidata.org/entity/Q34445288

about

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma Telomere length and risk of glioma Structural and functional analysis of the human POT1-TPP1 telomeric complex.Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair The effect of LOXL2 in hepatocellular carcinoma.Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation.Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma.Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma.Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

P2860

Q28390726-43427649-68F8-4CD2-9C00-6B9D6E17E5AF Q28396551-0FA59825-DAAE-48BC-905E-807B59B1146D Q33571860-8B599386-3AA1-4D74-BDFF-D6396B537395 Q33832767-ABBB1D3C-3461-4343-B066-010AF61067A4 Q37190899-FC4BD0A9-488D-4E00-9A3F-AE999AB3FFAD Q39108630-6F45A97F-4BC7-49B9-91CC-D71D17685991 Q39144903-241DBBA5-139B-4619-A912-15AF3C4BD6F7 Q40930271-8F44D8A8-D638-4DFE-BA9A-A0E56258A896 Q41721411-14C0D59C-C1FE-4F3F-BEE5-ABAB976D62F4 Q48014113-2EAC8FEB-BB21-414F-9C97-46B3C80A0A41 Q58579018-A17E09F6-9593-4C82-8503-8B76F4C04A23

P2860

Telomere profiling: toward glioblastoma personalized medicine.

http://www.wikidata.org/entity/Q34445288

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Telomere profiling: toward glioblastoma personalized medicine.

@ast

Telomere profiling: toward glioblastoma personalized medicine.

@en

Telomere profiling: toward glioblastoma personalized medicine.

@nl

type

label

Telomere profiling: toward glioblastoma personalized medicine.

@ast

Telomere profiling: toward glioblastoma personalized medicine.

@en

Telomere profiling: toward glioblastoma personalized medicine.

@nl

prefLabel

Telomere profiling: toward glioblastoma personalized medicine.

@ast

Telomere profiling: toward glioblastoma personalized medicine.

@en

Telomere profiling: toward glioblastoma personalized medicine.

@nl

P1433

Q34445288-C5D83BCE-7B8F-4D4A-AC8E-A2CBC3BD36BA

P1476

Q34445288-850B1531-BAE8-4DDA-85B2-C98BB01D99F6

P2093

Q34445288-004A9E46-2A82-44AE-8C81-DD177E5B005F

Q34445288-1E831085-0962-4A1D-96A4-8104F24102A6

Q34445288-44A66139-1A3C-41DA-915B-E3F4F02EA6B2

Q34445288-53E8971E-BEF2-41AC-8B90-5803AAE50B1F

Q34445288-6B17D8BD-2352-4C79-854F-B818897CE09C

Q34445288-6DD7E09E-5D47-42F5-B7A2-2708ABE62B57

Q34445288-8229221E-C9CB-4AFB-BCEA-5D5390BCF3A5

Q34445288-88BE5526-42CB-4A8E-90C4-23187BDC61A1

Q34445288-9EC05B19-168E-4823-8605-912C9AE6E16B

Q34445288-A217DBE2-543E-49B9-94CF-20E23D9B3F71

P2860

Q34445288-0301E77B-B1C4-43DF-96C4-C33C8CB82514

Q34445288-0E0E2144-24CD-4791-AD42-2E63C5EC8363

Q34445288-10C21B21-7403-44FA-AA18-40A4415B8C8E

Q34445288-110A0AAE-D383-40C9-9DC2-47422FCDE4FE

Q34445288-1559A023-3A94-4461-83A7-18222BB4C869

Q34445288-1AEFF4DC-1D1C-467A-9BE3-798AF5E7A6CE

Q34445288-274929A9-9FCC-41DA-A08E-681D5267D4A6

Q34445288-3356A84D-6B35-422F-A2BF-E3445533AC5F

Q34445288-35993F24-DABE-4DB4-B50C-F26A17B462C1

Q34445288-41009837-A49A-4426-9146-6ADDEF7EE0D2

P2888

Q34445288-3E5B7DBE-6D14-4A78-B6C5-A3534C8E34EA

P304

Q34445288-94188760-94B9-4C94-8424-A6444361D5D1

P31

Q34445288-7FE32667-7338-4D51-9987-13C77303341A

P356

Q34445288-D574BAB3-0050-4941-8463-EA50D3501613

P433

Q34445288-FE50C8BC-7AD6-47D8-BB91-FAEE74A2DE5D

P478

Q34445288-F9F31602-4618-4451-942E-D2CF6F30741F

P577

Q34445288-ECF77771-95F8-47D8-B3E8-18392FC5581B

P5875

Q34445288-3A52930D-5C1E-4EA9-812C-91816FE800AD

P6179

Q34445288-B43F8539-DD09-4674-86C3-98E5F0785E91

P698

Q34445288-EEC792BB-EEB1-46DD-8BBC-7374D5B2A6C8

P356

S12035-012-8363-9

P1433

Molecular Neurobiology

P1476

Telomere profiling: toward glioblastoma personalized medicine.

@en

P2093

Claire Rodriguez-Lafrasse

http://www.w3.org/2001/XMLSchema#string

Céline Malleval

http://www.w3.org/2001/XMLSchema#string

Delphine Poncet

http://www.w3.org/2001/XMLSchema#string

Gersende Alphonse

http://www.w3.org/2001/XMLSchema#string

Janice Royds

http://www.w3.org/2001/XMLSchema#string

Julien Carras

http://www.w3.org/2001/XMLSchema#string

Jérôme Honnorat

http://www.w3.org/2001/XMLSchema#string

Michael Beuve

http://www.w3.org/2001/XMLSchema#string

Noelyn Hung

http://www.w3.org/2001/XMLSchema#string

Paul Saultier

http://www.w3.org/2001/XMLSchema#string

P2860

POT1 as a terminal transducer of TRF1 telomere length control

POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The three-dimensional organization of telomeres in the nucleus of mammalian cells

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation

TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA.

Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.

The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome.

P2888

s12035-012-8363-9

P304

64-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-012-8363-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232247794

http://www.w3.org/2001/XMLSchema#string

P6179

1010151762

http://www.w3.org/2001/XMLSchema#string

P698

23065374

http://www.w3.org/2001/XMLSchema#string